3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Urinary Bladder Neoplasms
1
Trigeminal Neuralgia
1
Spinal Stenosis
1
Spinal Fractures
1
Spinal Diseases
1
Spinal Curvatures
1
Spinal Cord Neoplasms
1
Prostatic Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1
Hydrocephalus
1
Brain Neoplasms
1
Brain Diseases
1
Aneurysm
1
Interventions
XENP 1595
2
Cancer Vaccines
2
Bevacizumab
2
Adjuvants, Immunologic
2
veliparib
1
glutathione pegylated liposomal doxorubicin
1
etoposide phosphate
1
elacestrant
1
binimetinib
1
abemaciclib
1
Trastuzumab
1
Temozolomide
1
Radiotherapy
1
Radiation
1
RAD1901
1
Patient Discharge
1
PF-07284890
1
Midazolam
1
Etoposide
1
Dasatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Brain Diseases
×
Patient Discharge
×
Clear all
NCT03593330
2025-05-02
TCP
Barts & The London NHS Trust
Phase NA
Terminated
242 enrolled